No news is strange, if they are in discussions regarding price then I beleive the market should be imformed.If the offer is well below fair value then it should be clearly rejected along with some prediction as to the future value of Hyro 2012 .
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025